BZG2
BZG2 is an allosteric inhibitor for the SARS-CoV-2 main protease (Mpro), with an IC50 of 77 µM[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV; Virus Protease
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/bzg2.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC=CC=C1)N/C(NC2=CC=C([N+]([O-])=O)C=C2)=N\C3CCCCC3
Molecular Formula
C20H22N4O3
Molecular Weight
366.41
References & Citations
[1]de Santiago-Silva KM, et al., Molecular modelling studies and in vitro enzymatic assays identified A 4- (nitrobenzyl) guanidine derivative as inhibitor of SARS-CoV-2 Mpro. Sci Rep. 2024 Apr 14;14 (1) :8620.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![[Tyr0]-C-Type Natriuretic Peptide (32-53), human, porcine, rat](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
E-PP-0322-01 1 mg
[Tyr0]-C-Type Natriuretic Peptide (32-53), human, porcine, rat
Sign In for Pricing
View Details E-PP-0322-02 10 mg
[Tyr0]-C-Type Natriuretic Peptide (32-53), human, porcine, rat
Sign In for Pricing
View Details E-PP-0322-03 5 mg
[Tyr0]-C-Type Natriuretic Peptide (32-53), human, porcine, rat
Sign In for Pricing
View Details 